Eliem Therapeutics, Inc.ELYMNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-15.56M
↑ 27% above average
Average (5y)
$-21.45M
Historical baseline
Range
High:$-5.01M
Low:$-37.37M
CAGR
+25.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-15.56M | +24.5% |
| 2023 | $-20.60M | +44.9% |
| 2022 | $-37.37M | -3.6% |
| 2021 | $-36.07M | -155.9% |
| 2020 | $-14.10M | -181.5% |
| 2019 | $-5.01M | - |